| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |